Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susana Banerjee

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Clinical Medicine (London, England)|April 23, 2010
Becoming a new consultant: how to make it work for youSusana Banerjee
Steroids|March 29, 2011
The combination of VEGF inhibitors and anti-oestrogen therapies in breast cancerSusana Banerjee
Nature Reviews. Clinical Oncology|December 19, 2018
Reply to 'Physician burnout: let's avoid unsubstantiated claims'Susana Banerjee
Lancet (London, England)|August 1, 2017
Bevacizumab in cervical cancer: a step forward for survivalSusana Banerjee
Current Oncology Reports|March 28, 2013
Personalized therapy in gynecological cancer: a reality in clinical practice?Susana Banerjee, Martin Gore
Current Oncology Reports|September 14, 2011
PARP inhibitors in BRCA gene-mutated ovarian cancer and beyondSusana Banerjee, Stan Kaye
Expert Opinion on Investigational Drugs|July 20, 2017
Nintedanib in ovarian cancerSaira Khalique, Susana Banerjee
Nature Reviews. Clinical Oncology|September 23, 2018
Let's address burnout in oncologists and reimagine the way we workKrithika Murali, Susana Banerjee
The Oncologist|July 14, 2009
The future of targeted therapies in ovarian cancerSusana Banerjee, Martin Gore
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
The role of targeted therapy in ovarian cancerSusana Banerjee, Stan Kaye
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Clinical Medicine (London, England)|April 23, 2010
Becoming a new consultant: how to make it work for youSusana Banerjee
Steroids|March 29, 2011
The combination of VEGF inhibitors and anti-oestrogen therapies in breast cancerSusana Banerjee
Nature Reviews. Clinical Oncology|December 19, 2018
Reply to 'Physician burnout: let's avoid unsubstantiated claims'Susana Banerjee
Lancet (London, England)|August 1, 2017
Bevacizumab in cervical cancer: a step forward for survivalSusana Banerjee
Current Oncology Reports|March 28, 2013
Personalized therapy in gynecological cancer: a reality in clinical practice?Susana Banerjee, Martin Gore
Current Oncology Reports|September 14, 2011
PARP inhibitors in BRCA gene-mutated ovarian cancer and beyondSusana Banerjee, Stan Kaye
Expert Opinion on Investigational Drugs|July 20, 2017
Nintedanib in ovarian cancerSaira Khalique, Susana Banerjee
Nature Reviews. Clinical Oncology|September 23, 2018
Let's address burnout in oncologists and reimagine the way we workKrithika Murali, Susana Banerjee
The Oncologist|July 14, 2009
The future of targeted therapies in ovarian cancerSusana Banerjee, Martin Gore
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
The role of targeted therapy in ovarian cancerSusana Banerjee, Stan Kaye
Pageof 18